MAGIS PHARMA

Dissolved and wound up KBO/BCE: BE 0500.721.819

MAGIS PHARMA

Follow Report

Holdings

own accounts to 26-07-2024, the bar shows equity in euros

This companyMAGIS PHARMA3 holdings, 1 country accounts to 26-07-2024

Source: list of holdings in its own 26-07-2024 accounts. Every holding stands with its own latest accounts.

Magis Pharma Group via TJ Management (at MAGIS PHARMA until 2024), DB Consortium (at MAGIS PHARMA until 2024) and BD STRATEGY (at MAGIS PHARMA until 2024) · deeds of 27-06-2024 and 16-04-2021 founded in 2021	turnover €868,488 (2025)
TENDOTOOLS via DB Consortium, at MAGIS PHARMA until 2024 · Director · deed of 07-01-2025 founded in 1996	6.7 FTE (2025)
GOD'S PLAN via DB Consortium (at MAGIS PHARMA until 2024) and BD STRATEGY (at MAGIS PHARMA until 2024) · Director · deeds of 07-01-2025 and 07-07-2023 founded in 2023	total assets €1.9m (2025)
Curavex via TJ Management (at MAGIS PHARMA until 2024) and DB Consortium (at MAGIS PHARMA until 2024) · Director (not named in the articles) · deed of 12-11-2025	founded in 2025
DBC Operations via DB Consortium, at MAGIS PHARMA until 2024 · Director · deed of 06-03-2026	founded in 2026
BD STRATEGY via DB Consortium, at MAGIS PHARMA until 2024 · Manager (not named in the articles) · deed of 02-03-2023 No longer active

3 holdings

Share, source and own figures per holding (3)

Source for every holding own accounts 26-07-2024

FRAVERsubsidiary
Equity €293,471 Loss of €31,291 in 2023 (profit of €193,802 in 2022)

100%
Magis-Pharmasubsidiary
Equity €247,993 Loss of €374,469 in 2025 (loss of €1.5m in 2024) Checked score 53

100%
PARCHIMsubsidiary
Equity -€23,818 Loss of €22,327 in 2025 (loss of €32,429 in 2024)

100%

Holdings through the years 2015 to 2024

Source: list of holdings in its own accounts

Depth

Shared directors

This company Company Director Shareholding +N: links not shown yet